与实施生物标志物测试和改善其在癌症护理中的临床采用策略相关的因素:使用理论领域框架进行系统审查
Rehana A Salam1,2, Kate L A Dunlop1,2, Tuba N Gide2,3,4
1The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.
JCO precision oncology
|October 9, 2025
概括
在癌症护理中实施生物标志物测试面临挑战,原因是临床医生的知识和患者理解不一致. 瘤委员会和教育等策略可以提高吸收率,但需要更多的研究来解决障碍.
科学领域:
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 生物标志物测试对于个性化癌症护理至关重要,指导治疗决策.
- 尽管有其潜在的益处,生物标志物测试的临床采用仍然低于最佳水平.
研究的目的:
- 综合有关影响生物标志物测试在癌症护理中的实施因素的证据.
- 确定改善临床采用生物标志物测试的策略.
主要方法:
- 在2024年7月之前对MEDLINE,EMBASE和CENTRAL数据库进行系统审查.
- 应用理论领域框架,从临床医生和患者的角度分析实施因素.
- 确定增强生物标志物测试普及的策略.
主要成果:
- 临床医生报告说,在测试解释,治疗建议和沟通不确定性方面存在知识差距.
- 患者对生物标志物测试,其治疗相关性和研究过程的理解有限.
- 障碍包括长时间的交付时间,保险问题,后勤限制,对测试应用的担忧,以及不切实际的患者期望.
- 很少有研究评估干预措施,尽管瘤委员会,多学科协调和教育是经常报告的策略.
- 教育干预表明了可行性,可接受性和知识增强.
结论:
- 许多因素可以促进生物标志物测试的实施和临床采用.
- 需要进一步评估战略,以解决生物标志物测试现有的不确定性和障碍.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K


